ArticleOncoimmunology2022
CDK4/6 blockade provides an alternative approach for treatment of mismatch-repair deficient tumors.
Inken Salewski et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
15 papers cite it
this papercites it
ArticleOncoimmunology2022
Inken Salewski et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.